Eurofarma Laboratorios S.A.

The fourth quarter marked a continuation of weak earnings for many major South Korean pharma firms, hurt by factors including the continued impact of a long-running doctors’ protest against medical r

In a blowout year that saw three separate companies each achieve multiple honors, Sandoz emerged as the biggest winner of the Global Generics & Biosimilars Awards 2024, sponsored by IQVIA. Sandoz to

Several major South Korean pharma companies reported strong earnings in the fourth quarter and for the whole of 2022, led by in-house developed or other key prescription drugs, as well as growing over

Accord Healthcare and Sandoz have emerged as the major winners at the Global Generics & Biosimilars Awards 2022, with Accord picking up four trophies and Sandoz being crowned the winner in two cate